Dupont De Nemours, Inc. (DD) Stock Price & Analysis
Dupont De Nemours, Inc. (DD) rose 0.15% to USD 47.06 as of June 9, 2026 at 22:36 UTC, according to Nexqual real-time market data.
DD last closed at USD 46.99; the session ranged USD 45.89–47.9 on volume of 2,181,270 shares. Market capitalization is $19.06B, with a 52-week range of USD 27.45–52.66 (NYQ). Source: Nexqual, June 9, 2026 at 22:36 UTC.
Key Statistics (as of June 9, 2026 at 22:36 UTC)
| Price | USD 47.06 |
|---|---|
| Change | ▲ 0.15% (up) |
| Previous Close | USD 46.99 |
| Open | USD 47.65 |
| Day Range | USD 45.89 – 47.9 |
| 52-Week Range | USD 27.45 – 52.66 |
| Volume | 2,181,270 shares |
| Market Cap | $19.06B |
| Exchange | NYQ |
Technical Analysis (DD)
Nexqual's technical model rates DD "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 9, 2026 at 22:36 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 47.83 (neutral) |
| vs SMA50 | Below (USD 47.38) |
| MACD | -0.12 (negative) |
Analyst Ratings (DD)
Wall Street analysts rate DD "Strong Buy" based on 15 analysts, with a mean price target of USD 57.07 (range USD 52–64), per Nexqual as of June 9, 2026 at 22:36 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 15 |
| Mean Target | USD 57.07 |
| High Target | USD 64 |
| Low Target | USD 52 |
| Buy / Hold / Sell | 13 / 3 / 0 |
Earnings (DD)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 0.59 |
| Revenue Estimate | $1.81B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.55 vs est 0.48 ▲ beat |
| 2025-12-31 | USD 0.46 vs est 0.43 ▲ beat |
| 2025-09-30 | USD 1.09 vs est 0.98 ▲ beat |
| 2025-06-30 | USD 1.12 vs est 1.06 ▲ beat |
Source: Nexqual, June 9, 2026 at 22:36 UTC.
Financials & Fundamentals (DD)
| Total Revenue | $6.92B |
|---|---|
| Revenue Growth (YoY) | +4.30% |
| Gross Margin | +35.01% |
| Operating Margin | +13.80% |
| Profit Margin | -0.42% |
| ROE | +0.90% |
| Debt / Equity | 22.59 |
| Current Ratio | 2.68 |
| Total Cash | $710.00M |
| Total Debt | $3.22B |
| Free Cash Flow | $-124.75M |
Source: Nexqual, June 9, 2026 at 22:36 UTC.
Financial Health Score (DD)
Nexqual rates Dupont De Nemours, Inc.'s overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 22:36 UTC.
| Growth | Critical — Revenue -45% YoY (annual), sharp decline |
|---|---|
| Profitability | Solid — Gross margin 35%, operating 14% |
| Balance Sheet | Strong — $710M cash vs $3.22B debt |
| Cash Flow | Weak — FCF negative: -$125M, burning cash |
| Efficiency | Weak — ROE 1%, ROA 2.0% |
Ownership (DD)
| Insider Ownership | +0.19% |
|---|---|
| Institutional Ownership | +80.95% |
| Shares Outstanding | 405.06M |
| Float | 408.20M |
| Short % of Float | +3.30% |
Source: Nexqual, June 9, 2026 at 22:36 UTC.
Leadership (DD)
Dupont De Nemours, Inc. is led by Lori D. Koch (age 50), CEO & Director, per Nexqual as of June 9, 2026 at 22:36 UTC.
| CEO & Director | Lori D. Koch (age 50) |
|---|---|
| Senior VP & CFO | Antonella B. Franzen (age 49) |
| President of Healthcare & Water Technologies | Jeroen Bloemhard (age 56) |
| Chief Technology Officer | Marty DeGroot |
Major Backers & Investors (DD)
Notable institutional backers of Dupont De Nemours, Inc. include Invesco, Morgan Stanley, Victory Capital Management Inc., according to Nexqual as of June 9, 2026 at 22:36 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 2.94% |
| Morgan Stanley | 2.01% |
| Victory Capital Management Inc. | 1.55% |
| Fidelity | 1.29% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 20.92% |
| BlackRock | 9% |
| State Street | 5.82% |
| Geode Capital | 2.75% |
| Nuveen | 1.61% |
| Northern Trust | 1.29% |
Source: Nexqual, June 9, 2026 at 22:36 UTC.
From Dupont De Nemours, Inc.'s Latest SEC 10-K Filing (filed 2026-02-17)
Key Strengths & Strategy (as disclosed to the SEC)
- DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa.
- It operates through two segments, Healthcare & Water Technologies and Diversified Industrials.
- The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors.
- It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DOW | Dow Inc. | USD 33.22 | ▼ 2.21% |
| MMM | 3M Company | USD 156.39 | ▲ 1.71% |
| AA | Alcoa Corporation | USD 72.41 | ▲ 0.72% |
| HON | Honeywell International Inc. | USD 215.7 | ▲ 0.81% |
| CAT | Caterpillar, Inc. | USD 914.7 | ▲ 1.15% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 22:36 UTC. This page is informational and not investment advice.